Monitoring research on symptoms and quality of life using electronic patient-reported outcome (ePRO) in patients undergoing chemotherapy for metastatic breast cancer

Monitoring research on symptoms and quality of life using electronic patient-reported outcome (ePRO) in patients undergoing chemotherapy for metastatic breast cancer - ePRO monitoring research on metastatic breast cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036858

Enrollment

200

Registered

2019-09-01

Start date

2019-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metastatic breast cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Those who have been diagnosed as "histologically primary breast cancer" 2) Patients who are diagnosed with metastatic breast cancer and difficult to cure 3) Those who are or are planning to take chemotherapy for metastatic breast cancer 4) Persons who obtained written consent for participation in research

Exclusion criteria

Exclusion criteria: 1)Those who have difficulty in answering ePRO 2) A person in charge of research who has judged that incorporation into research is inappropriate

Design outcomes

Primary

Measure	Time frame
progression free survival	—

Countries

Japan

Contacts

Public ContactNaruto Taira

Okayama university hospital breast and endocrine surgery

ntaira@md.okayama-u.ac.jp0862357265

Outcome results